US Patent 10662160 Crystalline salts of a plasma kallikrein inhibitor
Patent 10662160 was granted and assigned to BioCryst Pharmaceuticals on May, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10662160 Crystalline salts of a plasma kallikrein inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.